AtaiBeckley Inc. - Common Stock (NQ:ATAI)

7.350 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

31 32 Next >

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock? ↗

September 07, 2026

The big story today with Eli Lilly is its hugely successful GLP-1 drugs, but the long-term story is likely to be about its acquisitions.

Via The Motley Fool

Atai Beckley (NASDAQ:ATAI) Clears Minervini Trend Template and High-Growth Momentum Screen ↗

September 05, 2026

Via Chartmill

AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI

August 17, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Why Eli Lilly Stock Climbed Today ↗

August 05, 2026

Demand for the healthcare leader's weight-loss drugs continues to rise.

Via The Motley Fool

A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout

August 05, 2026

Issued on behalf of Helus Pharma (Nasdaq: HELP)

From USA News Group

Via GlobeNewswire

Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock ↗

July 29, 2026

Lilly's pipeline is on track to pick up a handful of interesting new programs.

Via The Motley Fool

Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. ↗

July 29, 2026

Cathie Wood is loading up on shares of a biotech that could be one of the first entrants to the psychedelics market.

Via The Motley Fool

Topics ETFs Government

Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs ↗

July 28, 2026

The company isn't resting on its laurels.

Via The Motley Fool

Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗

July 23, 2026

Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline.

Via The Motley Fool

Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates

July 21, 2026

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Unusual volume stocks in Monday's session ↗

July 20, 2026

Via Chartmill

AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI

July 17, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Why AtaiBeckley Stock Soared Today ↗

July 16, 2026

The psychedelic drugmaker is being acquired.

Via The Motley Fool

Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion ↗

July 16, 2026

Today, July 16, 2026, the clinical-stage psychedelics developer jumped 33% after Lilly announced a cash deal plus milestone payments.

Via The Motley Fool

Topics Government Stocks

What's going on in today's session ↗

July 16, 2026

Via Chartmill

Curious about the most active stocks on Thursday? ↗

July 16, 2026

Via Chartmill

Power Movers: PRSO, ATAI, IQST, TGHL Watch Now

July 16, 2026

Via AB Newswire

Topics Artificial Intelligence Economy

Thursday's session: top gainers and losers ↗

July 16, 2026

Via Chartmill

Halper Sadeh LLC is Investigating Whether ATAI, CCRN, NUVL are Obtaining Fair Deals for their Shareholders

July 16, 2026

From Halper Sadeh LLC

Via GlobeNewswire

There are notable gap-ups and gap-downs in today's session. ↗

July 16, 2026

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)

July 16, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether AtaiBeckley Inc. is Obtaining a Fair Price for its Shareholders

July 16, 2026

From Halper Sadeh LLC

Via Business Wire

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

July 16, 2026

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 16, 2026

Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session. The market value of their outstanding shares is at $1.9 billion. Agape ATP (NASDAQ:ATPC) shares moved...

Via Benzinga

What This $496,000 Insider Sale at AtaiBeckley Means Amid Roughly 100% Stock Run ↗

July 09, 2026

Hershberg exercised vested options and liquidated them under a Rule 10b5-1 plan, halving direct equity while retaining 404,869 derivative securities.

Via The Motley Fool

Topics Regulatory Compliance

AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder

July 06, 2026

From AtaiBeckley Inc.

Via GlobeNewswire

AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets

June 25, 2026

From AtaiBeckley Inc.

Via GlobeNewswire

AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations

May 28, 2026

From AtaiBeckley Inc.

Via GlobeNewswire

AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026

May 27, 2026

From AtaiBeckley Inc.

Via GlobeNewswire

AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update

May 12, 2026

From AtaiBeckley Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.